[RGLS] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
04-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -0.00%
YoY- 5.59%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 18 18 18 18 18 204 483 -88.77%
PBT -14,506 -15,835 -21,736 -20,025 -20,015 -19,515 -21,098 -22.04%
Tax -58 -7 -128 -4 5 4 -8 273.24%
NP -14,448 -15,828 -21,608 -20,021 -20,020 -19,519 -21,090 -22.23%
Tax Rate - - - - - - - -
Total Cost 14,466 15,846 21,626 20,039 20,038 19,723 21,573 -23.33%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -80,266.67 -87,933.33 -120,044.44 -111,227.78 -111,222.22 -9,568.14 -4,366.46 592.84%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -16.68 -21.09 -48.76 -45.34 -45.39 -44.33 -47.95 -50.44%
EPS Diluted -16.68 -21.09 -48.76 -45.34 -45.39 -44.33 -47.95 -50.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.